Skin loses up to 30% of its dermal collagen in the first five years after menopause, then sheds roughly 2.1% more every year, according to published reviews of estrogen-deficient skin cited by dermatologists. Dr. Day puts the range even wider: 30–50% of collagen in those first five years, then roughly 2% annually. Skin thickness falls about 1.1% a year on top of that.

Davie, FL dermatologist Lesley Clark-Loeser, MD says the driver is one hormonal shift, not scattered aging complaints. Declining estrogen affects collagen production, elastin organization, hyaluronic acid content, barrier function, wound healing and the fibroblasts that maintain healthy skin. "The result is not simply 'aging,' but a distinct shift in the biology of skin that requires a different treatment approach," she says.

Who is driving the change?

Women are consulting earlier. "Women today are seeking consultation earlier, often during perimenopause rather than waiting until changes become advanced," Dr. Clark-Loeser says. In NewBeauty's State of Aesthetics Summer 2026 report, 34.1% of women named their 40s as the decade when aesthetic priorities feel most urgent; another 28.8% named their 50s — nearly two thirds pointing at the perimenopause and menopause decades.

Their demand is specific:

• 70.8% want topical skin care formulated for menopausal skin.
• 76.6% are open to energy-based treatments such as lasers and radio-frequency microneedling.
• Only 7.2% said they want to age without any aesthetic help at all.

Patients now ask about skin thinning, crepey texture, pigmentation changes, slower healing, facial volume loss and hair thinning, according to Dr. Clark-Loeser.

Why is hair in the same plan?

Hair thinning is part of the same hormonal picture. "Estrogen receptors are present throughout the skin and hair follicle, so hormonal changes influence multiple tissues simultaneously," Dr. Clark-Loeser says. "Hair may also become finer and less dense." Dr. Day sees patients with telogen effluvium triggered by hormonal fluctuation, and others with steady thinning and no shedding event. "Similar regenerative approaches are increasingly being used to support hair density in appropriately selected patients," Clark-Loeser says.

No single product answers the shift, so Dr. Day builds a full-year, multi-layered plan — skin care, devices, lasers and injectables. "It's always multi-layered because what's happening is multi-layered," she says. "Rather than thinking about one treatment replacing another, I think about how they work together," Clark-Loeser adds.

What does subtlety look like?

The goal is support, not volume. Dr. Day uses hyaluronic acid filler most often around the mouth — fine vertical lines on the upper lip in women who never smoked — delivered with a cannula. "It doesn't add bulk or weight. It adds support," she says. "This age group really doesn't want big lips. They just want hydrated lips, pretty lips, and they want the support around their mouth."

How do GLP-1s complicate it?

GLP-1 medications have layered a second biologic transition onto the first. "Significant or rapid loss of facial fat can accelerate visible volume depletion, making menopausal changes appear more pronounced," Dr. Clark-Loeser says. Her answer is whole-patient evaluation, not less weight loss: "The goal is not to reverse healthy weight loss, but to help patients maintain skin quality, facial balance, and overall vitality while they improve their health."

Dr. Day now refers patients out for menopause hormone therapy before any treatment. "We're really good at the treatments we're doing, but we're masking perimenopause instead of fully addressing it," she says. That gap — providers who can connect skin, hair, hormones and GLP-1-related change — is, by her account, the part of aesthetic medicine that has not yet caught up.